Watch STE. Know when insiders buy.
One email the day a filing lands. Free.
STE
STERIS plc
221.48
−3.70 −1.64%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
37
FLAG · shorts 37
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 6
buys / sells · latest disclosed Sep 25
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $21.6BP/E —DIV YIELD 1.14%FCF YIELD 4.29%REV TTM $6B +8.4%NET INCOME $805.1M +24.5%NET DEBT $1.2B52W 199.40 – 268.65SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jun 30 | $1.5B | +7.3% | 45.8% | $285.8M | $200.1M | +12.8% | — | $367.1M | $87.5M | $279.6M | Aug 7 |
| Q4 2026 · Mar 31derived | $1.6B | +7.3% | 43.9% | $316.8M | $220.2M | +51.2% | 2.24 | $335.4M | $90.2M | $245.2M | May 29 |
| Q3 2026 · Dec 31 | $1.5B | +9.2% | 43.8% | $273.2M | $192.9M | +11.2% | 1.96 | $298.2M | $98.7M | $199.5M | Feb 6 |
| Q2 2026 · Sep 30 | $1.5B | +9.9% | 44.2% | $265.8M | $191.9M | +27.9% | 1.94 | $287.8M | $86.5M | $201.3M | Nov 6 |
| Q1 2026 · Jun 30 | $1.4B | +8.7% | 45.1% | $246M | $177.4M | +22.0% | 1.79 | $420M | $93.6M | $326.4M | Aug 7 |
| Q4 2025 · Mar 31derived | $1.5B | +4.3% | 43.3% | $216.1M | $145.6M | — | 1.47 | $260.8M | $70.9M | $189.9M | May 29 |
| Q3 2025 · Dec 31 | $1.4B | +5.6% | 44.5% | $245.3M | $173.5M | +23.3% | 1.75 | $332.8M | $89.2M | $243.6M | Feb 6 |
| Q2 2025 · Sep 30 | $1.3B | +7.3% | 43.6% | $219.7M | $150M | +30.1% | 1.51 | $250.8M | $101.9M | $148.9M | Nov 6 |
| Q1 2025 · Jun 30 | $1.3B | — | 44.7% | $185.5M | $145.4M | — | 1.46 | $303.7M | $108.1M | $195.6M | Aug 7 |
| Q4 2024 · Mar 31 | $1.4B | — | 41.1% | $220.3M | −$1.4M | — | -0.01 | $254.8M | $91.5M | $163.4M | May 29 |
| Q3 2024 · Dec 31 | $1.3B | — | 43.2% | $226.5M | $140.7M | — | 1.42 | $291.2M | $118.9M | $172.3M | Feb 7 |
| Q2 2024 · Sep 30 | $1.2B | — | 44.1% | $191.6M | $115.3M | — | 1.16 | $146.1M | $83.3M | $62.8M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Mar 31 | $5.9B | 44.2% | $1.1B | $782.3M | 13.2% | 7.93 | $1.3B | $369M | $972.4M | $235.5M | $241.8M |
| FY2025 · to Mar 31 | $5.5B | 44.0% | $866.6M | $614.6M | 11.3% | 6.20 | $1.1B | $370.1M | $778M | $211.3M | $219.9M |
| FY2024 · to Mar 31 | $5.1B | 43.2% | $836.1M | $378.2M | 7.4% | 3.81 | $973.3M | $360.3M | $613M | $11.8M | $200.6M |
| FY2023 · to Mar 31 | $4.5B | 43.7% | $791.1M | $107M | 2.4% | 1.07 | $756.9M | $362M | $395M | $308.6M | $183.5M |
| FY2022 · to Mar 31 | $4.2B | 44.6% | $477.8M | $243.9M | 5.8% | 2.48 | $684.8M | $287.6M | $397.2M | $55.8M | $163.2M |
| FY2021 · to Mar 31 | $3.1B | 43.2% | $548.4M | $397.4M | 12.8% | 4.63 | $689.6M | $239.3M | $450.4M | $14.6M | $133.8M |
Every number comes from STERIS plc's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.